Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07385521Recruiting

The Use of Artificial Intelligence for the Prediction of Recurrence After Resection of Colorectal Liver Metastases

Role: lead

NCT06375915Phase 2Recruiting

Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

Role: lead

NCT03981497Recruiting

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Role: lead

NCT04394026Completed

Imaging Feature of SARS-CoV2 Infection

Role: lead

NCT03967951Completed

CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

Role: lead

NCT03967860Completed

Role of Post Surgery CT Following Laparoscopic Vertical Sleeve Gastrectomy

Role: lead

All 6 trials loaded